Abstract Pluripotency-associated transcription factors (PATF) play significant roles during early embryogenesis and in embryonic stem (ES) cells, such as control of cell-cycle progression, modulation of cellular metabolism, and transcriptional control of differentiation-inducing factors. The review aims to describe the current understanding of how these PATFs contribute to the early embryo and the ES-cell phenotypes. By a selection of representative examples of such PATFs, their roles are described, and some interesting questions are presented concerning their activity in pluripotent cells which have yet to be addressed.
Introduction
Early embryogenesis in mammals can be defined as the period of development before implantation (Rossant, 2007; Cockburn and Rossant, 2010; Wu et al., 2017) . After the process of fertilization and egg activation, DNA replication is initiated in both haploid genomes, followed by syngamy of pro-nuclei and the first mitotic division, thus forming the two-cell stage embryo (Rossant, 2007; Wu et al., 2017) . Moreover, the embryo goes through several rounds of cell divisions, denominated cleavages, that ultimately lead to a progressive reduction in blastomere volume ( Figure 1 ). During this period of embryonic development, blastomeres remain relatively similar in shape, and have limited adhesion among them. There is no transcription in the early embryo and its developmental coordination and timing are determined by maternal factors found in the egg (Latham, 1999; Wu et al., 2017) . Therefore, such cleavage divisions are rather fast in timing, with short G1 and G2 phases during the cell cycle (Frankenberg et al., 2016; Wu et al., 2017) .
After a variable number of cell divisions (i.e., 2-cell stage in mice, 8-16 cell transition in ruminants), embryos go through the embryonic genome activation (EGA) (Memili and First, 2000) . EGA activates the genes of the embryo that progressively dominate the transcriptional output of embryonic cells (Latham, 1999; Wu et al., 2017) . When the EGA is concluded, the embryo faces a period of compactation (Frankenberg et al., 2016) . At this stage, outer cells carry out a morphological change and acquire an epitheliallike morphology, in contrast to the spherical shape of inner cells in the embryo (Cockburn and Rossant, 2010; Wu et al., 2017) . This difference in blastomere morphology becomes more evident at the morula stage (Figure 1 ), alongside with transcriptional variations are observed in these two different cell types (Rossant, 2016; Wu et al., 2017) . At a discrete portion of the embryo, liquid begins to accumulate, leading to blastocele formation. The expansion of the blastocele occurs in parallel to the process of cellular differentiation that is culminated at the blastocyst stage (Figure 1) , with the segregation between the inner cell mass and trophectoderm (Rossant, 2007; Wu et al., 2017) . There are significant differences in embryo morphology among mammalian species (Frankenberg et al., 2016) , although their functional properties remain similar.
The process of cellular differentiation that was initiated during the compactation period is closed with the formation of the blastocyst (Cockburn and Rossant, 2010; Wu et al., 2017) . The outer cells of the blastocyst make the trophectoderm, thus carrying an epithelial-like morphology and give the three-dimensional structure of the blastocyst. The inner cell mass (ICM) is composed of round cells aggregated in a three-dimensional structure and adhered to the trophectoderm.
More importantly, these morphological changes are accompanied by contrasting functional and developmental potency abilities (Wu et al., 2017) . The trophectoderm gives rise to all cell types that make up the placenta, while the ICM has the potential to form all cell types that make up the fetus (Cockburn and Rossant, 2010; Rossant, 2016) .
Totipotency
The tremendous developmental capacity of early embryos has been the focus of intense experimentation since the XIX century (Tagarelli et al., 2004) . Initial studies relied on amphibian embryos, which are relatively large, easy to culture in simple solutions, have considerable size compared to their mammalian counterparts, and are more resistant to experimental manipulation (Gurdon, 2006) . The mechanical isolation of two blastomeres in a frog embryo resulted in the formation of two tadpoles, thus proving that such cells retain the capacity to give rise to the whole organism (Tagarelli et al., 2004) . Similar experiments were carried out with mammalian embryos up to the eight-cell stage (Moore, 1968; Willadsen, 1981) , leading to the understanding that this developmental potency, denominated totipotency, is also retained in such embryos. Thus, totipotency is defined as the capacity to derive all cell types that make up the fetus and the placenta (Rossant, 2016) . Remarkably, no cell type retains the totipotency state after the EGA.
Pluripotency
The pluripotent state is defined as the capacity of a cell to differentiate into all tissues of the three germ layers, namely endoderm, mesoderm, and ectoderm. Pluripotent cells display high nuclear to cytoplasm ratio, multiple nucleoli, relatively short cell cycles, among other distinctive features (Smith, 2001) . The ICM differentiates into the epiblast and hypoblast, that will form the fetus and amniotic sac, respectively (Cockburn and Rossant, 2010; Rossant, 2016) . The epiblast cells also give rise to primordial germ cells (PGC) (McLaren, 2000) , that migrate to gonadal ridges and form the germ cells lineages (Barton et al., 2016) .
The introduction of ICM pluripotent cells into recipient embryos demonstrates that these cells contribute to the formation of mots, if not all, tissues in the fetus (Nagy et al., 1990; Picard et al., 1990) . By using modified embryos that progressively contribute exclusively to placenta formation, the introduction of pluripotent cells allows the formation of viable fetuses (Nagy et al., 1990) .
The isolation and in vitro culture of the ICM under defined conditions allow the establishment of cultures of pluripotent cells coined as embryonic stem (ES) cells (Evans and Kaufman, 1981; Smith, 2001; Buehr et al., 2008; Li et al., 2008) . These ES cells maintain a typical morphology and can be propagated indefinitely in culture (Smith, 2001; Moura, 2012) . When exposed to differentiationinducing factors, such as growth factors and cytokines, they exit the pluripotent state and differentiate into multiple cell types both in vitro and in vivo (Smith, 2001) . Moreover, when subject to appropriate differentiation cues, ES cells are capable of forming relatively homogeneous populations of discrete cell types, such as motor neurons or cardiomyocytes (Smith, 2001; Wernig et al., 2007; Ichida et al., 2014) .
The introduction of ES cells in recipient embryos results in the formation of fetuses with contribution of cells of both origins (Bradley et al., 1984) . Moreover, since ES cells are pluripotent, they require a recipient embryo for the placenta formation (Nagy et al., 1990; Eggan et al., 2002) .
Collectively, these in vivo functional assays demonstrate the pluripotent nature of ES cells.
Unraveling the control of totipotency and pluripotency
The investigation at the molecular level of pluripotency in early embryos holds several challenges, such as fast developmental kinetics, transcription-independent development during cleavage stages, cellular differentiation in a relatively short period, and limited stating biological material for experimentation (Hochedlinger and Jaenisch, 2006; Moura, 2012) . Due to these factors, most investigations on pluripotency control relies on ES cells, thus contributing to a fast-paced understanding of the mechanism (Hochedlinger and Jaenisch, 2006; Moura, 2012) . In humans, ES cells require different culture conditions compared to mouse counterparts to sustain pluripotency and self-renewal (Amit et al., 2000; Chen et al., 2015) .
The genetic ablation of a gene contributes to the determination of its functions since cell phenotype lacking the factor can be readily observed (Capecchi, 1989 (Capecchi, , 2005 . By the identification of genes required for pluripotency, their characterization began to increase (Nichols et al., 1998; Niwa et al., 2000; Chambers et al., 2003; Dejosez et al., 2008) .
The genes required for the maintenance of pluripotency or that play central roles in this cellular state are collectively called pluripotency genes (Li and Belmonte, 2017) . Initially, pluripotency genes were identified as those with expression restricted to pluripotent or totipotent cells, namely germ cells, oocytes, early embryos, and ES cells (Schöler et al., 1989; Chambers et al., 2003; Mitsui et al., 2003) . With the increasing number of pluripotency genes characterized (Heng et al., 2010) , it became evident that few of such genes indeed have a pluripotency-specific gene expression profile.
The number of pluripotency genes characterized continues to grow and thus seems to be relatively far from saturation (Subramanian et al., 2009; Zheng and Hu, 2014) . Therefore, the mechanisms by which pluripotency genes control this cellular state is expected to grow in players and complexity in the foreseeable future. This understanding should contribute to better understanding of the mechanisms of totipotency, pluripotency, embryonic development, and selfrenewal of ES cells. The dissection of how each pluripotency gene contributes to the pluripotency state has shed light on how this cellular state is controlled at the molecular level (Table 1) . ICM: inner cell mass. E6.5-7.5: 6.5 and 7.5 embryonic days post-coitus, respectively.
Pluripotency-Associated Transcription Factors
Genes characterized for pluripotency control are predominantly composed of transcription factors, thus pluripotency-associated transcription factors (PATF) (Young, 2011; Yeo and Ng, 2013) . These PATFs act on gene regulation, by inducing or silencing target genes. Several PATFs are required for the establishment of cellular states, acting as sole factors, but more frequently in an orchestrated manner to control. dozens or hundreds of downstream target genes (Boyer et al., 2005; Kim et al., 2008; Young, 2011) .
A new striking demonstration of the importance of pluripotency genes was demonstrated by the cellular reprogramming of mouse and human somatic cells with their ectopic expression Yamanaka, 2006, 2016; Takahashi et al., 2007) . These induced pluripotent stem (iPS) cells, closely resemble and are functionally similar to embryo-derived ES cells (Maherali et al., 2007; Okita et al., 2007; Wernig et al., 2007; Ichida et al., 2014) .
Selection of Functionally-investigated PATFs C-MYC
CMYC is part of a family of transcription factors composed of C-MYC, N-MYC, and L-MYC (Fagnocchi and Zippo, 2017) . The C-MYC gene displays diverse functions in pluripotent cells, such as cell cycle control, cellular metabolism, modulation of signaling pathways, epigenetic control of target genes, and other transcription factors, such as HOX genes (Fagnocchi and Zippo, 2017) . Both CMYC and NMYC show similar expression patterns during mouse preimplantation development and are functionally redundant for pluripotency (Smith et al., 2010) . The expression of CMYC has also been analyzed in preimplantation embryos of ruminants species (Miles et al., 2012; Madeja et al., 2013; Singh et al., 2014; Silva et al., 2017) , but its functional roles in such species remain to be described. Dosage-sensitive sex reversal, adrenal hypoplasia critical region, chromosome X, gene 1 (DAX1) DAX1 (NR0B1) was detected in oocytes and during all embryonic development of several species (Clipsham et al., 2004; Stickels et al., 2015; Moura et al., 2017; Silva et al., 2017) . The characterization of mice lacking DAX1 demonstrated to be dispensable for early embryonic development (Table 1) , implantation, and oogenesis (Yu et al., 1998) . In contrast, male germ cells do not complete spermatogenesis due to progressive degeneration of the germinative testicular epithelium in mice lacking DAX1 (Yu et al., 1998) .
Alternatively, DAX1 contributes to cellular reprogramming by facilitating the reactivation of other pluripotency genes (Zhang et al., 2014; Lujan et al., 2015) , although the requirement of its activity to maintain pluripotency remains controversial (Khalfallah et al., 2009; Zhang et al., 2014) . The understanding of DAX1 downstream targets in both pluripotent cells and during reprogramming may shed light on how this PATF play such contrasting roles.
Glis family zinc finger 1 (GLIS1)
GLIS1 was identified in a prospection of transcription factors that are involved in cellular reprogramming . Its expression in mice is enriched in eggs and zygotes, but lower in ES cells, fibroblasts, and other somatic cell types . It is possible that GLIS1 was not previously identified as a pluripotency gene since its expression is quite similar between somatic and pluripotent cells . In cattle, GLIS1 is more abundant in eggs, embryos up to the fourstage embryo and is barely detected at the eight-cell stage (Takahashi et al., 2015) . The knockdown of GLIS1 after fertilization blocks embryonic development at the eight-cell stage, possibly due to a partial or complete block of embryonic genome activation (Takahashi et al., 2015) . The genomewide binding profile of GLIS1 in ES cells may be informative about its roles during development and possibly for understanding its contribution to cellular reprogramming.
Kruppel-Like Factor 5 (KLF5)
KLF5 is part of the Kruppel-like family of transcription factors, composed of 17 members, with diverse activities in several biological processes such as cellular proliferation, metabolism, stress response, among others (Diakiw et al., 2013; Farrugia et al., 2016) . KLF5 holds stable expression throughput embryonic development in mice and is required for maintenance of pluripotency (Ema et al., 2008; Parisi and Russo, 2011) . The influence of KLF5 on mouse pluripotency depends on the regulation of other pluripotency genes and silencing of genes responsible for cellular differentiation (Parisi and Russo, 2011) . The genes KLF2, KLF4, and KLF5 seen to hold redundant activities in mouse ES cells (Jiang et al., 2008) . These genes share multiple targeted downstream genes, particularly NANOG, while concomitant silencing of all three genes is required for loss of pluripotency in ES cells (Jiang et al., 2008) . Further efforts trying to phenocopy the cellular effects of KLF members in ES cells (i.e., modulation of signaling pathways) should be instructive in understanding their roles in pluripotency and development.
NANOG
NANOG is another major PATF that controls pluripotency and is required for development (Mitsui et al., 2003) . NANOG is a homeodomain protein, with a unique DNA-protein interaction domain and relatively low homology across species (Chambers et al., 2003) . In the mouse, NANOG is expressed after embryo compactation and remains restricted to ICMforming cells (Chambers et al., 2003) . The expression of NANOG in livestock is found throughout preimplantation development (He et al., 2006; Gossis and Cibelli, 2014) . NANOG is required for both ES cell pluripotency in vitro and in vivo (Chambers et al., 2003; Mitsui et al., 2003) . NANOG shares hundreds of target genes with OCT4 and SOX2 (Boyer et al., 2005; Loh et al., 2006) . However, NANOG should be functionally investigated in greater detail during early development and among species.
Octamer-binding transcription factor 4 (OCT4)
The OCT4 gene was the first pluripotencyassociated transcription factor described in early embryos (Schöler et al., 1989 (Schöler et al., , 1990 Rosner et al., 1990) and also the first functionally investigated (Nichols et al., 1998; Niwa et al., 2000; Zeineddine et al., 2014) . OCT4 displays expression restricted to germ cells, oocytes, early preimplantation embryos, and ES cells. The silencing of OCT4 causes the formation of blastocysts lacking a pluripotent ICM (Table 1) , thus with developmental potential restricted to trophoblastderived lineages (Nichols et al., 1998) . Curiously, trophoblast cells require paracrine signaling from pluripotent cells, to retain their bona fide state and viability (Nichols et al., 1998; Le Bin et al., 2014) . Although cleavage-stage embryonic development occurs without OCT4, the segregation between epiblast and primitive endoderm is extinguished in ICM cells lacking OCT4 (Le Bin et al., 2014) .
The investigation of the OCT4 function at the genomic level has substantially contributed to the understanding of how OCT4 acts upon the control of pluripotency (Boyer et al., 2005; Loh et al., 2006; Zeineddine et al., 2014) . OCT4 forms heterodimers with SOX2 and other TFs (Rizzino, 2013) , to regulate hundreds of downstream target genes in mouse and human ES cells (Boyer et al., 2005; Loh et al., 2006) . The OCT4-SOX2 complex activates other pluripotency genes, controls several signaling pathways, and silences differentiationinducing developmental regulators (Boyer et al., 2005; Rizzino, 2013; Zeineddine et al., 2014) . The investigation of OCT4 at the genome-wide level across species should shed light on how this PATF master regulator evolved to contribute to the control of pluripotency.
RONIN (THAP11)
RONIN was identified as a factor that physically interacts with Caspase 3 in mouse ES cells during differentiation (Dejosez et al., 2008) . It was previously demonstrated that NANOG protein cleavage by Caspase 3 was a mechanism for induction of ES cell differentiation (Fujita et al., 2008) . In an investigation of proteins that bind to NANOG in ES cells, RONIN (THAP11) was identified as a candidate factor. Curiously, RONIN was dispensable for early embryogenesis, and its target genes were not shared by the core transcriptional circuitry established by OCT4, SOX2, and NANOG (Boyer et al., 2005; Dejosez et al., 2008) . This fact suggested that RONIN contributes differently than these other PATFs to the control of pluripotency. A follow-up analysis showed that RONIN participates in the control of cellular processes such as transcription initiation, alternative splicing, and cellular metabolism (Dejosez et al., 2010) . The association of RONIN to HCF-1 contributes to ES cells self-renewal and pluripotency by elevating the expression of genes responsible for protein synthesis, and energy production (Dejosez et al., 2010) . The molecular circuitry formed by RONIN needs to be further explored to elucidate better how this PATF contribute to pluripotency in embryos and ES cells.
SOX2
SOX2 is one of the twenty members of the Sry-related HMG box family of transcription factors with various roles during development (Avilion et al., 2003) . SOX2 forms a heterodimer with OCT4 and binds to motifs near each other in the genome (Boyer et al., 2005; Rizzino, 2013; Zeineddine et al., 2014) . The SOX2 mRNA and protein are detected throughout preimplantation development in several mammalian species and becomes restarted to the ICM (Avilion et al., 2003; Goissis and Cibelli, 2014) , but its requirement for development was demonstrated in cattle (Goissis and Cibelli, 2014; Sakurai et al., 2016) . The unraveling of SOX2 requirement during preimplantation development of certain species should be an attractive area of investigation.
Zinc Finger Protein 281 (ZFP281)
ZFP281 (Znf281) was identified as a pluripotency gene due to its differential expression between mouse somatic and ES cells (Wang et al., 2006) . More recently, its expression has been described in early embryos of ruminant species Silva et al., 2017) . The requirement for ZFP281 to maintain pluripotency remains conflicting (Table 1) , possibly due to differences in experimental conditions such as gene silencing approach and ES cell culture conditions (Wang et al., 2006; Fidalgo et al., 2011) . ZFP281 forms complexes with NANOG, OCT4, and SOX2 in ES cells (Wang et al., 2006 , thus suggesting to be a downstream factor of the OCT4-SOX2-NANOG circuitry. Moreover, ZFP281 controls several downstream target genes with the above ciruitry, although its primary role is their expression fine-tuning, including other pluripotency genes Fidalgo et al., 2011) . Due to this function on other pluripotency genes, ZFP281 reduces the efficiency of cellular reprogramming by defined factors through blocking NANOG reactivation (Fidalgo et al., 2012) .
Zinc Finger Protein, X-Linked (ZFX)
The temporal expression of ZFX during embryonic development has been described in several species and was one of the first X-linked genes characterized (Bernardi et al., 1996; Yu et al., 1998; Peippo et al., 2002) . ZFX has a homolog on the Y chromosome, denominated ZFY, with stable expression throughout the preimplantation development of male embryos (Bernardi et al., 1996) . Moreover, embryos lacking ZFX can reach the blastocyst stage and survive until implantation (Luoh et al., 1997; Galan-Caridad et al., 2007) . In contrast, it was demonstrated that ZFX is necessary for both mouse and human pluripotency (GalanCaridad et al., 2007; Harel et al., 2012) . It remains an open question why ES cells are dependent on ZFX in contrast to early embryos.
Final Considerations
Pluripotency has been a focus of intense investigation over the past two decades. Considerable progress has been made toward understanding how a subset of genes, namely pluripotency-associated transcription factors, contribute to the establishment and maintenance of such a cellular state. Due to the intrinsic limitations posed by early preimplantation embryos for experimentation and likely culture-induced effects of ES cell propagation, future investigations should continue to be based on these two systems as converging approaches. Investigations in livestock and other species (aside from mice and humans) should also shed light on how pluripotency is controlled at the molecular level across mammalian species.
